Neurogene (NGNE) executive Cobb received 16,500 shares

Insider transactions reported

Stuart Cobb (Chief Scientific Officer at Neurogene Inc., NGNE) reported that they received 16,500 shares on Feb 20, 2026. After these transactions the filing shows 37,294 shares held directly.

Reporting person

Cobb Stuart

Role

Chief Scientific Officer

Holdings before and after

• Common Stock: 20,794 to 37,294 direct

Footnotes from the filing

1. 1. Consist of 16,500 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
2. 2. Consist of (a) 13,594 restricted stock units remaining from a grant of 20,391 restricted stock units granted on March 13, 2024, which vests annually in equal installments on March 13, 2025, March 13, 2026 and March 13, 2027; (b) 7,200 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (c) 16,500 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ